HKEX Stock Code: 01093English|繁體|简体

Highlight - Results for the first quarter of 2026

Revenue
RMB6,465M, -7.8%
Reported profit attributable to shareholders of the Company
RMB860M, -41.8%
Underlying profit attributable to shareholders of the Company
RMB842M, -40.3%
Basic earnings per share (based on reported profit)
RMB7.54 cents, -41.6%

Key Products

Finished drugs
Bulk drugs
© Copyright 2026 CSPC Pharmaceutical Group Limited. All Rights Reserved.